A groundbreaking trial for an HIV vaccine. New ways to help the body heal itself. Immunotherapy treatments for cancer. Behind medical advancements like these are the brilliant scientists who are relentlessly pushing their visions and research forward.
Trillions of beneficial bacteria live in and all around us. What if we could use them to our advantage, to do everything from prevent diabetes to reduce inflammation? Dirk Gevers, Ph.D., Global Head of the Janssen Human Microbiome Institute, shares how his team is already well on that research path.
From partnering with the Black AIDS Institute to reduce HIV infection rates to improving representation in clinical trials, learn how Johnson & Johnson has made it a mission to help address disparities in healthcare.
From the incredible researchers who've dedicated their life's work to fighting chronic diseases to those who work tirelessly to bring hope to underserved populations, we're taking a moment to celebrate the company's many heroes.
The app now has new and improved features designed to help make managing diabetes easier, including the ability to sync with the OneTouch Verio Flex® blood glucose monitoring system through built‐in Bluetooth® Smart Technology.
It affects nearly one in 10 pregnancies—even if the mother-to-be didn't have diabetes before she conceived. Two experts on the condition share what you should know to help keep you and your baby healthy.
From the decadent desserts to the workout-unfriendly weather, winter's a tough time to be dealing with diabetes. So we asked an expert for practical solutions to help keep your health in check—without having to skip the pecan pie.
Every 19 seconds, someone in the U.S. learns they have type 2 diabetes. That’s three people every minute who face a dangerous road ahead: If left unchecked, diabetes can lead to heart attack, stroke, kidney disease, blindness—and even death .
When you think of stem cell treatments, you probably picture a patient with an immune disorder or cancer. But thanks to a new partnership between Johnson & Johnson’s Janssen Biotech, Inc. and biotech company ViaCyte, Inc., there’s a new wave of stem cell research being conducted that holds a lot of promise for people with Type 1 diabetes.